{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:49:01Z","timestamp":1782204541217,"version":"3.54.5"},"reference-count":37,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Objective: To report a rare case of bilateral iris metastasis from small cell lung carcinoma (SCLC) and systematically review the literature on SCLC-associated iris metastases, with emphasis on clinical presentation, management, and outcomes. Materials and Methods: A systematic literature review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed, ScienceDirect, Scopus, and Web of Science were comprehensively searched on 10 July 2025. Eligible studies included English-language reports of iris metastasis originating from SCLC in human subjects. Case report: A 58-year-old woman with previously treated SCLC developed bilateral iris metastases one year after complete remission of the primary tumor. Ophthalmic examination revealed whitish-gray, vascularized iris masses with iridocorneal angle involvement, associated with secondary angle-closure glaucoma and markedly elevated intraocular pressure (48 mm Hg) in the left eye. Cyclocryotherapy, preceded by systemic and topical antiglaucoma therapy, resulted in pain relief and a reduction in intraocular pressure; the patient died four months later due to pneumonia. Results (Systematic Review): Seventeen studies comprising 17 patients were included; the median age was 60 years, and 64.7% were male. The median interval from SCLC diagnosis to ocular presentation was 4 months, although iris metastasis was occasionally the initial or concurrent manifestation of disease. The most common presenting features were visual impairment (58.8%), ocular pain (41.2%), and elevated intraocular pressure (41.2%), while iris neovascularization (35.3%) and synechiae (29.4%) were also frequent. Bilateral involvement was reported in only one previous case. Treatment approaches were heterogeneous and included antiglaucoma therapy, systemic chemotherapy, local radiotherapy, anti-VEGF therapy, and enucleation. Among patients with available follow-up (n = 12), 58.3% died within a median follow-up of 7.5 months. Conclusions: Bilateral iris metastasis from SCLC is rare and may occur as a manifestation of recurrent disease after remission. It is an aggressive condition characterized by nonspecific ocular symptoms, variable management, and poor survival, underscoring the importance of early recognition and the need for evidence-based diagnostic and therapeutic strategies.<\/jats:p>","DOI":"10.3390\/clinpract16070118","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:13:37Z","timestamp":1782195217000},"page":"118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bilateral Iris Metastasis of Small Cell Lung Carcinoma: A Case Report and Systematic Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3025-6870","authenticated-orcid":false,"given":"Stipe","family":"Vidovi\u0107","sequence":"first","affiliation":[{"name":"Clinic for Eye Diseases, Clinical Hospital Centre Osijek, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egon","family":"Biuk","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"},{"name":"Department of Orthopedics, Clinical Hospital Centre Osijek, 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Biuk","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-2657","authenticated-orcid":false,"given":"Marija","family":"Jeli\u0107 Vukovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, Clinical Hospital Centre Osijek, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Vinkovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, Clinical Hospital Centre Osijek, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1587-298X","authenticated-orcid":false,"given":"Andrijana","family":"Kopi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, Clinical Hospital Centre Osijek, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravka","family":"Biuk","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, Clinical Hospital Centre Osijek, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1442-9071.2007.01550.x","article-title":"Management of Metastatic Carcinoma of the Uveal Tract: An Evidence-based Analysis","volume":"35","author":"Kanthan","year":"2007","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0161-6420(97)30148-1","article-title":"Survey of 520 Eyes with Uveal Metastases","volume":"104","author":"Shields","year":"1997","journal-title":"Ophthalmology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gerba-G\u00f3recka, K., Romanowska-Dixon, B., Karska-Basta, I., Ciepli\u0144ska-Kechner, E., and Nowak, M.S. (2025). Clinical Characteristics and Management of Ocular Metastases. Cancers, 17.","DOI":"10.3390\/cancers17061041"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/meajo.MEAJO_6_18","article-title":"Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin","volume":"25","author":"Shields","year":"2018","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ICO.0000000000000285","article-title":"Iris Metastasis from Systemic Cancer in 104 Patients: The 2014 Jerry A. Shields Lecture","volume":"34","author":"Shields","year":"2015","journal-title":"Cornea"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-Cell Lung Cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14744\/bej.2023.39200","article-title":"Bilateral Iris Metastasis in a Patient with Small Cell Lung Carcinoma: A Case Report","volume":"9","author":"Ciftci","year":"2024","journal-title":"Beyoglu Eye J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_9","first-page":"2127","article-title":"Methodological Quality of Case Series Studies: An Introduction to the JBI Critical Appraisal Tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ophtha.2013.07.014","article-title":"Uveal Metastasis from Lung Cancer","volume":"121","author":"Shah","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archopht.1974.01010010286003","article-title":"Carcinoma Metastatic to the Eye and Orbit: I. A Clinicopathologic Study of 227 Cases","volume":"92","author":"Ferry","year":"1974","journal-title":"Arch. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.4081\/cp.2011.e39","article-title":"Intracameral Bevacizumab Administered for Non-Small Cell Lung Cancer Metastasis to Iris","volume":"1","author":"Schell","year":"2011","journal-title":"Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archopht.126.4.572","article-title":"Pulmonary Metastasis Masquerading as Anterior Uveitis","volume":"126","author":"Kesen","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9394(14)71227-9","article-title":"Metastatic Tumors to the Iris in 40 Patients","volume":"119","author":"Shields","year":"1995","journal-title":"Am. J. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000544159","article-title":"A Case Report of Intravitreal Aflibercept for Iris Metastasis from Small Cell Lung Carcinoma with Neovascular Glaucoma","volume":"16","author":"Goto","year":"2025","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1759-7714.14818","article-title":"Iris Metastasis as Resistance Mechanism to Atezolizumab, Carboplatin, and Etoposide but Responds to Additional Irinotecan and Anlotinib in a Small Cell Lung Cancer Patient","volume":"14","author":"Huang","year":"2023","journal-title":"Thorac. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e236405","DOI":"10.1136\/bcr-2020-236405","article-title":"Ophthalmic Anterior Segment Metastasis Masquerading as Uveitis","volume":"14","author":"Nguyen","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000492713","article-title":"A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma","volume":"9","author":"Hidaka","year":"2018","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_19","first-page":"00258","article-title":"Simultaneous Retinal and Iris Metastases in Small Cell Lung Carcinoma","volume":"8","author":"Chen","year":"2018","journal-title":"Adv. Ophthalmol. Vis. Syst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e21522","DOI":"10.5812\/ircmj.21522","article-title":"Iris Metastasis in a Patient with Small Cell Lung Cancer: A Case Report","volume":"18","author":"Sakellakis","year":"2016","journal-title":"Iran. Red Crescent Med. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3892\/ol.2017.5648","article-title":"Iris Metastasis as the First Sign of Small Cell Lung Cancer: A Case Report","volume":"13","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/JTO.0000000000000201","article-title":"Iris Metastasis from Small-Cell Lung Cancer","volume":"9","author":"Hata","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5114\/wo.2013.35288","article-title":"Small-Cell Lung Carcinoma Metastasis to the Iris\u2014Case Presentation","volume":"3","author":"Nikratowicz","year":"2013","journal-title":"Wsp\u00f3\u0142czesna Onkol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s13691-012-0026-1","article-title":"Asymptomatic Iris Metastasis of Small-Cell Lung Cancer","volume":"1","author":"Fukui","year":"2012","journal-title":"Int. Cancer Conf. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10384-010-0892-z","article-title":"Intravitreal Bevacizumab for Iris Metastasis of Small-Cell Lung Carcinoma with Neovascular Glaucoma","volume":"55","author":"Nakashima","year":"2011","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/030089160809400524","article-title":"Diabetes Insipidus Caused by Pituitary Gland Metastasis Accompanied by Iris Metastasis of Small Cell Lung Cancer: Case Presentation and Review of the Literature","volume":"94","author":"Fidan","year":"2008","journal-title":"Tumori J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/JTO.0b013e31815ba210","article-title":"Iris Metastasis in Small-Cell Lung Carcinoma","volume":"2","author":"Roenhorst","year":"2007","journal-title":"J. Thorac. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3129\/i06-077","article-title":"Clinical, Histologic, and Immunohistochemical Evaluation of Iris Metastases from Small Cell Lung Carcinoma","volume":"41","author":"Moura","year":"2006","journal-title":"Can. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00007611-199006000-00022","article-title":"Bilateral Uveal Metastases from Small-Cell Carcinoma of the Lung","volume":"83","author":"Ampil","year":"1990","journal-title":"South. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/1097-0142(19800515)45:10<2521::AID-CNCR2820451009>3.0.CO;2-5","article-title":"Carcinoma Metastatic to the Anterior Ocular Segment: Response to Chemotherapy","volume":"45","author":"Sierocki","year":"1980","journal-title":"Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Russo, A., Avitabile, T., Reibaldi, M., Bonfiglio, V., Pignatelli, F., Fallico, M., Caltabiano, R., Broggi, G., Russo, D., and Varricchio, S. (2020). Iris Melanoma: Management and Prognosis. Appl. Sci., 10.","DOI":"10.3390\/app10248766"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0161-6420(83)34500-0","article-title":"The Differential Diagnosis of Malignant Melanoma of the Iris","volume":"90","author":"Shields","year":"1983","journal-title":"Ophthalmology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/ceo.14380","article-title":"Cysts and Tumours of the Iris: Diagnostic Tools and Key Management Considerations\u2014A Review","volume":"52","author":"Kim","year":"2024","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal Melanoma: Trends in Incidence, Treatment, and Survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bjophthalmol-2014-305218","article-title":"Evaluation of Iris and Iridociliary Body Lesions with Anterior Segment Optical Coherence Tomography versus Ultrasound B-Scan","volume":"99","author":"Hau","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"112458","DOI":"10.5662\/wjm.v16.i1.112458","article-title":"Are Iris Masses in Lung Carcinoma Always a Metastasis: Two Case Reports","volume":"16","author":"Nayak","year":"2026","journal-title":"World J. Methodol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.survophthal.2025.12.009","article-title":"Comparative Effectiveness and Safety of Intra-Arterial Chemotherapy and Intravenous Chemotherapy for Retinoblastoma: A Systematic Review and Meta-Analysis","volume":"71","author":"Chen","year":"2026","journal-title":"Surv. Ophthalmol."}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/16\/7\/118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:08:32Z","timestamp":1782202112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/16\/7\/118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["clinpract16070118"],"URL":"https:\/\/doi.org\/10.3390\/clinpract16070118","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}